APA (Adapted Physical Activity) for Patients With Advanced Melanoma

Summary

APA (adapted physical activity) for patients with advanced melanoma APA (adapted physical activity) for patients with advanced melanoma undergoing treatment: evaluation of a personalized program at the hospital Melanoma is a malignant tumor developed from melanocytes. It accounts for approximately 4% of all incident cancers and 1.2% of cancer deaths, regardless of sex. Since 2011, the advent of new therapies (targeted therapies and immunotherapies) has revolutionized the management of advanced-stage melanoma (unresectable stage III or stage IV). These treatments have led to a significant improvement in the prognosis of metastatic melanoma, with a 5-year overall survival rate of 34% for targeted therapies, 44% for monotherapy with immunotherapy, and 52% for the combination of nivolumab + ipilimumab. Due to the improvement in survival rates, advanced melanoma has become a chronic disease affecting all ages. It is therefore essential to maintain the quality of life for these patients.

Eligibility

Inclusion Criteria:

* Male or female patient aged 18 or older
* Advanced melanoma treated adjuvantly or curatively with immunotherapy or targeted therapy
* Patient who has read and understood the information letter and does not object to participating in the study
* Member of or beneficiary of a social security scheme
* Patients who have agreed to participate in the adapted sports module

Exclusion Criteria:

* Minor patient
* Melanoma not requiring systemic treatment
* Condition making 6-month follow-up impossible
* Protected incapacitated persons (judicial protection, guardianship, curatorship, deprivation of liberty)

Conditions2

Browse More Trials